Episode 075: Intro to CAR-T, Bispecifics (BiTE), and Autologous Transplant

Episode 075: Intro to CAR-T, Bispecifics (BiT...

Rouleaux University Medical CenterRouleaux University Medical Center

Up next

Episode 161: Career Development Series- Building a Career in Clinical Research

This week, we are so excited to share the third episode of our Career Development Series episodes, developed in partnership with The American Society of Hematology, The ASH Trainee Council, and Hematopoiesis! For years, our listeners have reached out to our show asking for guidan ...  Show more

 . 27min 42sec
Episode 160: Head and Neck Cancer Series, Pt. 3 – Discussion with ENT

Throughout this series, we have discussed how multidisciplinary the management of head and neck cancer is and the critical role that our surgical colleagues play in the management of this disease. This week, we welcome Dr. Michael Topf, Associate Professor for Associate Professor ...  Show more

 . 36min 0sec

Recommended Episodes

CAR T-cell Therapy in AML: State of the Art
EHA Unplugged

Tune in to our podcast for an in-depth discussion on immunotherapeutic strategies for Acute Myeloid Leukemia (AML). In this episode, we feature Dr Sarah Tettamanti, a senior scientist at the Fondazione Tettamanti Research Centre in Italy, who shares her expertise on CAR T-cell th ...  Show more

 . 15min 1sec
S2 Episode 3: When Is the Best Time to Use CAR T-Cell Therapy in Multiple Myeloma?
Medscape InDiscussion: Multiple Myeloma

Joseph Mikhael, MD, and Krina K. Patel, MD, MSc, discuss considerations for CAR T-Cell therapy in multiple myeloma, including age, access, and bridging therapy. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002715. ...  Show more

 . 24min 38sec
CAR T-Cells and Safety Signals
Intention to Treat

This episode examines CAR T-cell therapy’s early successes, broader promise, and emerging risks, as the FDA considers reports of occasional secondary cancers. A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2400701. 

 . 25min 25sec
263. Cytokines Everywhere All at Once: Approach to CRS and ICANS
The Intern At Work: Internal Medicine

Send us Fan MailAs a result of the rapid adoption CAR-T therapy for certain lymphoid malignancies and multiple myeloma, of these treatments, CRS and ICANS will become more common in IM wards in the coming years. Take a listen to learn about how to treat this emerging condition. T ...  Show more

 . 17min 17sec